Fundsmith 13F: Cuts Manhattan Associates (MANH) Stake by $23M

Fundsmith recently cut its position in Manhattan Associates, Inc. (NasdaqGS: MANH) by 58%, according to its latest 13F filing with the SEC. The fund sold 167,444 shares, bringing its holdings down to 120,888 shares, valued at approximately $17.28 million as of the reporting period.

What Changed in Fundsmith's Manhattan Associates Position

Fundsmith's decision to reduce its stake in Manhattan Associates led to a significant decrease in its holdings from 288,332 shares to 120,888 shares, a reduction of 167,444 shares. This change represents a 58% decrease in its position, reflecting a strategic move in its investment portfolio.

Other Institutional Activity in Manhattan Associates

Several other institutional investors have also adjusted their positions in Manhattan Associates. BlackRock, Inc. increased its stake by 584,749 shares, bringing its total to 6,844,538 shares valued at about $911.14 million. Vanguard Portfolio Management LLC initiated a new position with 3,869,749 shares worth approximately $515.14 million. T. Rowe Price Investment Management, Inc. added 964,239 shares, ending with 3,544,480 shares valued at $471.84 million. FMR LLC increased its holdings by 244,298 shares to 3,303,397 shares, worth around $439.75 million. Meanwhile, AQR Capital Management LLC boosted its position by 942,513 shares to 3,162,052 shares, valued at $416.63 million.

Manhattan Associates, Inc. Stock Down 34.1%

Shares of Manhattan Associates currently trade around $142.92. The company boasts a market cap of $8.46 billion, with a P/E ratio of 40.0 and a forward P/E of 24.0. Its beta stands at 0.962, indicating moderate volatility compared to the market. The stock's 52-week range spans from $119.06 to $247.22, with a 50-day moving average of $138.55 and a 200-day moving average of $165.13. The company maintains a current ratio of 1.104 and a quick ratio of 0.97, with a debt-to-equity ratio of 27.14.

Recent Earnings

In its most recent earnings report, Manhattan Associates posted revenue of approximately $1.10 billion, reflecting a growth of 7.4% year-over-year. The company achieved a net margin of 19.7% and a return on equity of 96.2%. The earnings per share stood at $3.57. The next earnings report is scheduled for July 21, 2026.

Insider Buying and Selling at Manhattan Associates, Inc.

Recent insider transactions at Manhattan Associates saw multiple executives purchasing shares on May 14, 2026. Kimberly Kuryea, Linda Hollembaek, Charles Moran, Danielle Sheer, and Eddie Capel each bought 1,940 shares. Meanwhile, President and CEO Eric Andrew Clark sold 1,000 shares on June 10, 2026, at an average price of $146.77.

Analysts Set New Price Targets

Barclays maintained its 'buy' rating for Manhattan Associates on May 29, 2026, with a price target of $201. Other firms like Citigroup, Baird, Stifel, and DA Davidson also maintained 'buy' ratings, with price targets ranging from $177 to $240. The consensus among 11 analysts suggests a 'buy' recommendation, with a mean price target of $184.

About Manhattan Associates

Manhattan Associates, Inc. is a technology company based in Atlanta, Georgia. It specializes in developing and maintaining software solutions for managing supply chains, inventory, and omni-channel operations. The company serves a variety of industries, including retail, consumer goods, logistics, and government, operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Led by CEO Eric A. Clark, Manhattan Associates employs approximately 4,390 people.

Bottom Line

Fundsmith's significant reduction in its Manhattan Associates holdings highlights a strategic portfolio adjustment. Despite this, other major institutional investors have shown confidence by increasing their stakes. Manhattan Associates continues to perform well financially, with strong earnings growth and positive analyst sentiment. Investors should note that 13F filings are backward-looking and might not fully reflect the current investment stance.